OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Obesity‐related glomerulopathy: Current approaches and future perspectives
José Ignacio Martínez‐Montoro, Enrique Morales, Isabel Cornejo‐Pareja, et al.
Obesity Reviews (2022) Vol. 23, Iss. 7
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Obesity and chronic kidney disease
Zongmiao Jiang, Yao Wang, Xue Zhao, et al.
AJP Endocrinology and Metabolism (2022) Vol. 324, Iss. 1, pp. E24-E41
Closed Access | Times Cited: 148

Relationship between gout, hyperuricemia, and obesity—does central obesity play a significant role?—a study based on the NHANES database
Tongjun Mao, Qian He, Junping Yang, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 20

Obesity-Related Chronic Kidney Disease: From Diagnosis to Treatment
Elena Avgoustou, Ilektra Tzivaki, Γεωργία Διαμαντοπούλου, et al.
Diagnostics (2025) Vol. 15, Iss. 2, pp. 169-169
Open Access | Times Cited: 1

Association between weight-adjusted-waist index and the risk of hyperuricemia in adults: a population-based investigation
Yunyi Ding, Zhuohan Xu, Xue Zhou, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 18

Visceral fat and attribute-based medicine in chronic kidney disease
Hiroshi Kataoka, Kosaku Nitta, Junichi Hoshino
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 17

Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)
Mariam M. Ali, Sanober Parveen, Vanessa Williams, et al.
Journal of Clinical & Translational Endocrinology (2024) Vol. 36, pp. 100341-100341
Open Access | Times Cited: 7

The role of perirenal adipose tissue deposition in chronic kidney disease progression: Mechanisms and therapeutic implications
Xiang Qiu, Xin Lan, L J Li, et al.
Life Sciences (2024) Vol. 352, pp. 122866-122866
Open Access | Times Cited: 6

Childhood Obesity: Insight into Kidney Involvement
Nazareno Carullo, Mariateresa Zicarelli, Ashour Michael, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17400-17400
Open Access | Times Cited: 13

Metformin alleviates sphingolipids dysregulation and improves obesity-related kidney disease in high fat diet rats
Xing Lin, Shanyu Wu, Ying Shi, et al.
Journal of Pharmacology and Experimental Therapeutics (2025) Vol. 392, Iss. 3, pp. 103388-103388
Closed Access

Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near
Gilda M. Portalatin, Irene Hong‐McAtee, Anna Burgner, et al.
Frontiers in Pediatrics (2025) Vol. 13
Open Access

Therapeutic effects and mechanistic insights of YiQiHuangDou decoction on high-fat diet-induced obesity-related Glomerulopathy (ORG) in mice
Xiaoxiao Liu, Longfei Zhang, Mingze Xu, et al.
Journal of Functional Foods (2025) Vol. 127, pp. 106728-106728
Closed Access

From fat to filter: the effect of adipose tissue-derived signals on kidney function
Nermin Ahmed, C. Dalmasso, M. Turner, et al.
Nature Reviews Nephrology (2025)
Closed Access

Sex-Related Differences in Cardiovascular Risk in Adolescents with Overweight or Obesity
Procolo Di Bonito, Anna Di Sessa, Maria Rosaria Licenziati, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 4, pp. 141-141
Open Access | Times Cited: 4

Relationships between obesity and prevalence of gout in patients with type 2 diabetes mellitus: a cross-sectional population-based study
Ningyu Cai, Mengdie Chen, Ping Feng, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4

Exploring Adiposity and Chronic Kidney Disease: Clinical Implications, Management Strategies, Prognostic Considerations
Laşin Özbek, Sama Mahmoud Abdel‐Rahman, S. Ünlü, et al.
Medicina (2024) Vol. 60, Iss. 10, pp. 1668-1668
Open Access | Times Cited: 4

Novel Insights in the Physiopathology and Management of Obesity-Related Kidney Disease
Justo Sandino, Marina Martín-Taboada, Gema Medina‐Gómez, et al.
Nutrients (2022) Vol. 14, Iss. 19, pp. 3937-3937
Open Access | Times Cited: 18

Kidney Considerations in Pediatric Obesity
Alexandra Sawyer, Evan Zeitler, Howard Trachtman, et al.
Current Obesity Reports (2023) Vol. 12, Iss. 3, pp. 332-344
Closed Access | Times Cited: 9

Role of perirenal adiposity in renal dysfunction among CKD individuals with or without diabetes: a Japanese cross-sectional study
Teruyuki Kono, Gulinu Maimaituxun, Hayato Tanabe, et al.
BMJ Open Diabetes Research & Care (2024) Vol. 12, Iss. 2, pp. e003832-e003832
Open Access | Times Cited: 3

The New Challenge of Obesity - Obesity-Associated Nephropathy
Mengjin Hao, You Lv, Siyuan Liu, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 1957-1971
Open Access | Times Cited: 3

Obesity-related glomerulopathy in children: connecting pathophysiology to clinical care
Guneive Mangat, Nikhil Nair, Oren Barat, et al.
Clinical Kidney Journal (2022) Vol. 16, Iss. 4, pp. 611-618
Open Access | Times Cited: 15

Tabersonine attenuates obesity‐induced renal injury via inhibiting NF‐κB‐mediated inflammation
Chenchen Qian, Jiong Wang, Wante Lin, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 6, pp. 2353-2363
Closed Access | Times Cited: 8

Kidney damage predictors in children with metabolically healthy and metabolically unhealthy obesity phenotype
Anna Di Sessa, Antonio Paride Passaro, Alberto Maria Colasante, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 12, pp. 1247-1255
Closed Access | Times Cited: 8

Page 1 - Next Page

Scroll to top